ChemoMetec A/S (CHEMM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ChemoMetec A/S (CHEMM) has a cash flow conversion efficiency ratio of 0.139x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr90.64 Million ≈ $14.18 Million USD) by net assets (Dkr652.59 Million ≈ $102.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View ChemoMetec A/S (CHEMM) share price today for real-time trading data and today's change.
ChemoMetec A/S - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how ChemoMetec A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see ChemoMetec A/S market capitalisation for the company's overall valuation and market capitalisation.
ChemoMetec A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ChemoMetec A/S ranked by their cash flow conversion efficiency. Also see CHEMM current and non-current assets for a full breakdown of the balance sheet.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kinco Automation (Shanghai) Co. Ltd. A
SHG:688160
|
N/A |
|
Vitrolife AB
ST:VITR
|
0.017x |
|
Shanghai Zijiang Enterprise Group Co Ltd
SHG:600210
|
0.074x |
|
Rusta AB (publ)
ST:RUSTA
|
0.081x |
|
JM Financial Limited
NSE:JMFINANCIL
|
-0.029x |
|
Guangzhou Ruoyuchen Information Tec
SHE:003010
|
0.373x |
|
FMC Corporation
NYSE:FMC
|
0.198x |
|
Hunan Yujing Machinery Co Ltd Class A
SHE:002943
|
0.105x |
Annual Cash Flow Conversion Efficiency for ChemoMetec A/S (2005–2025)
The table below shows the annual cash flow conversion efficiency of ChemoMetec A/S from 2005 to 2025. Review CHEMM FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | Dkr673.36 Million ≈ $105.35 Million |
Dkr207.45 Million ≈ $32.46 Million |
0.308x | +35.01% |
| 2024-06-30 | Dkr565.32 Million ≈ $88.45 Million |
Dkr129.00 Million ≈ $20.18 Million |
0.228x | -21.09% |
| 2023-06-30 | Dkr533.04 Million ≈ $83.40 Million |
Dkr154.15 Million ≈ $24.12 Million |
0.289x | -41.59% |
| 2022-06-30 | Dkr357.20 Million ≈ $55.89 Million |
Dkr176.86 Million ≈ $27.67 Million |
0.495x | +21.59% |
| 2021-06-30 | Dkr264.98 Million ≈ $41.46 Million |
Dkr107.90 Million ≈ $16.88 Million |
0.407x | +14.64% |
| 2020-06-30 | Dkr202.75 Million ≈ $31.72 Million |
Dkr72.02 Million ≈ $11.27 Million |
0.355x | +5.59% |
| 2019-06-30 | Dkr173.34 Million ≈ $27.12 Million |
Dkr58.31 Million ≈ $9.12 Million |
0.336x | -3.44% |
| 2018-06-30 | Dkr73.01 Million ≈ $11.42 Million |
Dkr25.44 Million ≈ $3.98 Million |
0.348x | +129.87% |
| 2017-06-30 | Dkr64.38 Million ≈ $10.07 Million |
Dkr9.76 Million ≈ $1.53 Million |
0.152x | -49.91% |
| 2016-06-30 | Dkr56.85 Million ≈ $8.89 Million |
Dkr17.20 Million ≈ $2.69 Million |
0.303x | +4.70% |
| 2015-06-30 | Dkr46.35 Million ≈ $7.25 Million |
Dkr13.39 Million ≈ $2.10 Million |
0.289x | +127.07% |
| 2014-06-30 | Dkr44.53 Million ≈ $6.97 Million |
Dkr5.67 Million ≈ $886.64K |
0.127x | -29.63% |
| 2013-06-30 | Dkr43.23 Million ≈ $6.76 Million |
Dkr7.82 Million ≈ $1.22 Million |
0.181x | -12.56% |
| 2012-06-30 | Dkr42.86 Million ≈ $6.71 Million |
Dkr8.87 Million ≈ $1.39 Million |
0.207x | +39.88% |
| 2011-06-30 | Dkr52.71 Million ≈ $8.25 Million |
Dkr7.79 Million ≈ $1.22 Million |
0.148x | +15.98% |
| 2010-06-30 | Dkr52.62 Million ≈ $8.23 Million |
Dkr6.71 Million ≈ $1.05 Million |
0.127x | -53.18% |
| 2009-06-30 | Dkr56.31 Million ≈ $8.81 Million |
Dkr15.33 Million ≈ $2.40 Million |
0.272x | +950.04% |
| 2008-06-30 | Dkr51.71 Million ≈ $8.09 Million |
Dkr1.34 Million ≈ $209.81K |
0.026x | +225.62% |
| 2007-06-30 | Dkr39.34 Million ≈ $6.15 Million |
Dkr-812.00K ≈ $-127.04K |
-0.021x | -170.06% |
| 2006-06-30 | Dkr16.50 Million ≈ $2.58 Million |
Dkr486.00K ≈ $76.04K |
0.029x | +18.05% |
| 2005-06-30 | Dkr-11.34 Million ≈ $-1.77 Million |
Dkr-283.00K ≈ $-44.28K |
0.025x | -- |
About ChemoMetec A/S
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, an… Read more